Skip to main content
logo
Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
23.78
+0.41 (1.75%)
Sep 11, 2026, 4:00 PM EDT - Market closed

Tango Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4,0101,1933321,010639958
Market Cap Growth
428.41%259.50%-67.13%57.94%-33.25%-
Enterprise Value
3,0281,07576689287461
Last Close Price
23.788.863.099.907.2510.94

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
74.5119.137.8927.6425.7225.86
PB Ratio
3.913.451.663.992.562.78
P/TBV Ratio
3.913.451.663.992.562.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
56.2617.241.8118.8711.5312.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.100.180.150.170.00
Net Debt / Equity Ratio
-0.96-0.89-1.11-1.18-1.30-1.40
Net Debt / EBITDA Ratio
7.312.841.552.672.978.44
Net Debt / FCF Ratio
6.812.211.672.492.787.88
Asset Turnover
0.080.170.120.090.050.11
Quick Ratio
49.9515.836.767.336.6311.98
Current Ratio
50.8216.326.987.546.7612.10
Return on Equity (ROE)
-21.34%-37.23%-57.58%-40.49%-36.41%-30.38%
Return on Assets (ROA)
-12.99%-19.45%-25.31%-17.01%-14.82%-10.28%
Return on Capital Employed (ROCE)
-12.90%-29.50%-52.30%-32.00%-29.20%-12.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.09%-8.51%-39.26%-10.08%-16.92%-6.08%
FCF Yield
-3.60%-11.73%-39.85%-11.84%-18.27%-6.41%
Buyback Yield / Dilution
-22.81%-6.35%-15.50%-7.69%-41.40%-94.50%
SEC Filings: 10-K · 10-Q